Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic Adipose-Derived MSCs for Refractory Acute GvHD
NCT02687646Phase 2Completed
- Start
- Feb 2017
- Primary completion
- Jan 2022
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CSCC_ASC in Acute Graft-Versus-Host Disease (aGvHD). Started Feb 2017; status: completed.
02
Drugs
CSCC_ASC
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT02687646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02687646.